The Changing Diabetes® in Children (CDiC), programme is part of Novo Nordisk's 'Access to Diabetes Care' strategy and builds on the UN-defined cornerstones in the right to health. The key objective of the programme is to contribute to meeting the fourth UN Millennium Goal- to reduce child mortality by breaking down the barriers that prevent children with type 1 diabetes in developing countries from receiving proper care. Presently operational in nine countries including Bangladesh, Cameroon, Democratic Republic of Congo, Ethopia, Guinea, Kenya, Uganda and Tanzania, India was the seventh country to roll out the programme. In India, we have reached out to over 4000 children with type 1 diabetes from economically underprivileged sections of society and provide them with comprehensive diabetes care.
To initiate and strive for sustainable comprehensive diabetes care for the economically underprivileged children with type 1 diabetes in India.
To improve the infrastructure, access to medication and awareness among patients and parents.
To work on capacity building among HCPs for improved management of children with type 1 diabetes.
To create the advocacy platform to get the attention of the Govt. and policy makers on specific needs of children with type 1 diabetes in India.
|CDIC Centers ~21 main & 27 satellite centers|
|Total registered Children with type 1 diabetes ~4063|
|Total doctors and paramedics ~6975|
For more information : Changing Diabetes® in Children